Global Antimicrobial Susceptibility Test Market is valued approximately at USD 3.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2020-2026. Antibacterial susceptibility testing is used to determine the specific drugs which can affect the particular bacteria. These tests provide guidance to the physician in drug preference and dosage for difficult-to-treat infections. The antimicrobial tests can provide better treatment facilities to cooperate with the complex situation which affects individuals of all ages and races. Rising incidences of antibacterial-resistant infections, increased funding, research grants, public-private investments, increasing government initiatives and focus on infection control in healthcare settings are the few factors responsible for high CAGR of the market over the forecast period. According to the Center for Disease Control and Prevention (CDC) based in the U.S. estimated that antibacterial resistance can cause more than 23,000 deaths and 2 million infections each year. Also, it is estimated that over 25,000 deaths owing to antibacterial-resistant infections caused in Europe every year. This, in turn, is expected to accelerate the demand for antimicrobial susceptibility tests, thus contributing to the growth of the global market. However, high cost of automated antimicrobial susceptibility testing systems, coupled with unfavorable reimbursement scenario are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.
The regional analysis of global Antimicrobial Susceptibility Test market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising incidence of antibiotic-resistant infections, coupled with the well-established awareness programs for precision medicine and the use of antimicrobial testing in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to increasingly becoming saturated and manufacturers and suppliers of antimicrobial susceptibility test products in the countries like China and India.
Major market player included in this report are:
Bio-Rad Laboratories, Inc.
Becton Dickinson, and Company
Thermo Fisher Scientific Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Manual Antimicrobial Susceptibility Testing
Automated Laboratory Instruments
Culture and Growth Media
Drug Discovery and Development
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Antimicrobial Susceptibility Test Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers